Johnson & Johnson (JNJ) 103.22 $JNJ
'Fast Money' Recap: Markets Start Another Week on Positive Note
at The Street - 1 hr 7 mins ago
The trading panel looked at the new post-split Apple and whether it's worth the investment.
Legal-Bay Lawsuit Settlement Funding Reports Finalization of $2.5 Billion Estimate in DePuy ASR Hip Settlements
PR Newswire - 1 hr 7 mins ago
Legal-Bay LLC, The Lawsuit Settlement Funding Company, disclosed today a new lawsuit cash advance program for clients with potential settlements in DePuy Orthopaedics Inc. litigations. In a late 2013 press release by parent company Johnson & Johnson and DePuy executives, the company stated "The U.S. settlement is valued at approximately $2.5 billion, based on an estimate of 8,000 patients participating in the program". The estimated 8,000 patients who filed against DePuy were facing ASR(TM) XL Acetabular Hip System or ASR(TM) Hip Resurfacing System complications and experienced pain, inflammation, infection to surrounding internal areas and tissue, and Metallosis. J&J, as well as the plaintiff's attorneys, have now announced that enough clients have opted-in for the settlement and that the settlement payments will be processed in the next few months.
Lupus Nephritis - Pipeline Review, H1 2014
M2 - 1 hr 25 mins ago
Research and Markets (http://www.researchandmarkets.com/research/fdzqtl/lupus_nephritis) has announced the addition of the "Lupus Nephritis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Lupus Nephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lupus Nephritis and special features on late-stage and discontinued projects. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Companies Mentioned: - Bristol-Myers Squibb Company - Baxter International Inc. - Johnson & Johnson - Biogen Idec Inc. - GlaxoSmithKline plc - Takeda Pharmaceutical Company Limited - Teva Pharmaceutical Industries Limited - Noxxon Pharma AG - Anthera Pharmaceuticals Inc. - Kadmon Pharmaceuticals, LLC - Azano Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/fd..._nephritis
Final Glance: Pharmaceuticals companies
AP - Mon Jun 09, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Jun 09, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Merck to pay $3.85B for hepatitis C drug developer
By LINDA A. JOHNSON - AP - Mon Jun 09, 4:37PM CDT
TRENTON, N.J. (AP) — Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.
Midday Glance: Pharmaceuticals companies
AP - Mon Jun 09, 12:20PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Jun 09, 12:20PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
By End of 2018 the Global Protein Therapeutics Market is Estimated to Reach US$ 165 Billion as New Products Enter the Sector
M2 - Mon Jun 09, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3s8lj/global_protein) has announced the addition of the "Global Protein Therapeutics Market Outlook 2018" report to their offering. According to this new research report, Global Protein Therapeutics Market Outlook 2018, a large number of market players has been developing monoclonal antibodies (mAbs). This research has found that mAbs contribute the largest shares in the number of protein therapeutic products under pipeline. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments. The report takes into account all the key aspects of the worldwide protein therapeutics market and projects the market during the period 2012-2018. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performances and last but not the least, current and future market sizes. Moreover, the report provides a summary of the recent trends that may have an impact on the future industry performance. Companies Mentioned: - Abbott Laboratories - Amgen Inc. - Biogen Idec Inc. - Eli Lilly & Company - Johnson & Johnson - Merck Serono S.A. - Novo Nordisk - Pfizer - Roche Group - Sanofi-Aventis For more information visit http://www.researchandmarkets.com/research/c3...al_protein About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Early Glance: Pharmaceuticals companies
AP - Mon Jun 09, 9:30AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon Jun 09, 9:30AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Critical Alerts For Groupon, Baidu.com, Johnson and Johnson, First Solar, and Chipotle Mexican Grill Technology Released By InvestorsObserver
PR Newswire - Mon Jun 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GRPN, BIDU, JNJ, FSLR, and CMG.
Achillion Pharma Might be Next Hep C Takeout Target
at The Street - Mon Jun 09, 8:22AM CDT
Johnson & Johnson and Abbvie were both reportedly interesting in buying Idenix but lost out to Merck, reports CNBC. Achillion shares are up almost 30% to $TK Monday as investors bet the losers in the Idenix sweepstakes may move on to the next target.
2014 MedTech Innovator Award Semi-Finalists Announced
Business Wire - Mon Jun 09, 8:01AM CDT
RCT Ventures announced the selection of the Top 10 semi-finalists in the 2014 MedTech Innovator competition, a medical device-focused venture competition that allows the audience to choose the winner. The Top 10 will now move on to compete live on-stage on June 12th for $175,000 in total prizes provided by RCT Ventures, and Johnson & Johnson Development Corporation (JJDC) and Janssen Labs during the 22nd Annual Medical Device Conference, hosted by law firm Wilson Sonsini Goodrich & Rosati (WSGR).
The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
M2 - Mon Jun 09, 4:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kc5qx4/the_world_market) has announced the addition of the "The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)" report to their offering. The Worldwide Market for Infusion Pumps This report, Infusion Pump Markets, is Kalorama Information's most current and complete research into infusion pump devices used for patient treatment and nutrition. With an aging population and increased need for healthcare services, this device is a high-interest area for several manufacturers. Kalorama's report details the important types of infusion pumps, projects revenues and discusses the key companies who manufacture and market them. For the purpose of this study, we have classified two general types of medical infusion pumps: traditional and specialty pumps: Issues and trends explored in this study include: - World demographics - Increasing life expectancy worldwide - Growing incidence of disease - Steady surgical procedure volumes - Infusion pump recalls - Reducing medication errors with new infusion pumps - Smart pump technology - Home infusion trends - Connectivity solutions and wireless networks - EMRs and infusion pump solutions - Infusion pump rentals and leasing - Infusion pumps and 'High-Alert' medications - Reducing hospital inpatient length of stay and increases in home health care - Medical device growth in emerging markets Several leading competitors and niche product developers are listed in the Manufacturer Profiles. The profiled companies include: - Animas/Johnson & Johnson - Baxter - B. Braun - CareFusion - Covidien - Fresenius Kabi - Hospira - I-Flow - Insulet - IRadimed - Medtronic - Moog - Roche - Smiths Group - Tandem Key Topics Covered: 1: EXECUTIVE SUMMARY 2: INDUSTRY OVERVIEW 3: MARKET TRENDS AND OPPORTUNITIES 4: TRADITIONAL INFUSION PUMPS 5: SPECIALTY INFUSION PUMPS 6: TOTAL MARKET ANALYSIS 7: MANUFACTURER MARKET SUMMARY AND PROFILES For more information visit http://www.researchandmarkets.com/research/kc...rld_market
Various Walmart Suppliers Supporting Children's Miracle Network Hospitals This Month
PRWeb - Mon Jun 09, 4:15AM CDT
As the six-week Walmart and Sam's Club register campaign wraps up this month, several Walmart initiatives and suppliers are continuing the effort to raise funds and awareness for Children's Miracle Network Hospitals, a charity supporting 170 children's hospitals across North America. Below are some of the upcoming activities: Through a relationship with Walmart supplier Proctor & Gamble, The ABC Family television series, Bet On Your Baby, will feature CMN Hospitals Miracle Child Joshua on Saturday, June 14 at 8:00 p.m. EST. Mom bloggers and consumers will be live tweeting throughout the episode from 8-9 p.m. EST. For each use of the #LuvsBOYB hashtag, one Luvs diaper will be donated to CMN Hospitals (up to 10,000 diapers). On June 17 at noon EST, Johnson & Johnson will host a Twitter party to build buzz around the Johnson Baby promotion where $1 from select purchases will benefit CMN Hospitals in June. Consumers can join the conversation by following the hashtaag #JohnsonBabyCARES. Now through August, Walmart supplier Johnson & Johnson will also donate $1 for photos shared on the Donate A Photo app. Users must select Children's Miracle Network Hospitals as the benefiting charity. Watch for specially marked Johnson & Johnson products for more details. CMN Hospitals signage in the Walmart Baby department will start appearing in stores across the nation this month featuring Miracle Child Ella and inviting customers to Put Your Money Where the Miracles Are. During June, $1 per purchase of any Johnson's Baby, Aveeno Baby and Desitin items, along with Infant Tylenol and Infant Motrin, up to $200,000, will go to CMN Hospitals. A portion of proceeds, up to $200,000, from all sales of Gerber products from May 14 - June 28 will benefit Children's Miracle Network Hospitals. Pampers and Walmart are also partnering to donate $200,000 to the charity. White Cloud, a paper products company, recently announced the winners of its tissue box design contest with Children's Miracle Network Hospitals. Four patients will have their artwork printed on special edition tissue boxes available exclusively at Walmart through June, and also earned a $15,000 donation and a yearlong supply of paper products for their hospitals. White Cloud will also donate an additional $95,000 to the charity and member hospitals. To find your Children's Miracle Network Hospital or for more information and to help kids in your community, visit http://www.CMNHospitals.org.
The Repercussions of Medicare's New Hepatitis C Push
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Sun Jun 08, 12:31PM CDT
This week, the Centers for Medicare & Medicaid Services, or CMS, announced a big shift in health policy. CMS intends to cover screening for hepatitis C for members who fall into either of two buckets: those who are considered to be at high risk...
3 Spectacular Ways Samsung Could Disrupt the Health Care Industry
Leo Sun, The Motley Fool - Motley Fool - Sat Jun 07, 10:05AM CDT
When most investors think of Samsung , they inevitably think of smartphones, tablets, and TVs. Yet over the past several years, Samsung has also beefed up its presence in the health care industry through investments in medical devices,...
As Dividend Stocks Go, Philip Morris Is Expensive: Here Is a Cheaper Pick
Rupert Hargreaves, The Motley Fool - Motley Fool - Sat Jun 07, 9:00AM CDT
Every portfolio should have a dividend stock at its core to provide a degree of diversification and stability. The best dividend stocks are usually found within the consumer goods sector as the sector's defensive nature means that cash flows are...
'Fast Money' Recap: Markets Start Another Week on Positive Note
at The Street - 1 hr 7 mins ago
The trading panel looked at the new post-split Apple and whether it's worth the investment.
Legal-Bay Lawsuit Settlement Funding Reports Finalization of $2.5 Billion Estimate in DePuy ASR Hip Settlements
PR Newswire - 1 hr 7 mins ago
Legal-Bay LLC, The Lawsuit Settlement Funding Company, disclosed today a new lawsuit cash advance program for clients with potential settlements in DePuy Orthopaedics Inc. litigations. In a late 2013 press release by parent company Johnson & Johnson and DePuy executives, the company stated "The U.S. settlement is valued at approximately $2.5 billion, based on an estimate of 8,000 patients participating in the program". The estimated 8,000 patients who filed against DePuy were facing ASR(TM) XL Acetabular Hip System or ASR(TM) Hip Resurfacing System complications and experienced pain, inflammation, infection to surrounding internal areas and tissue, and Metallosis. J&J, as well as the plaintiff's attorneys, have now announced that enough clients have opted-in for the settlement and that the settlement payments will be processed in the next few months.
Lupus Nephritis - Pipeline Review, H1 2014
M2 - 1 hr 25 mins ago
Research and Markets (http://www.researchandmarkets.com/research/fdzqtl/lupus_nephritis) has announced the addition of the "Lupus Nephritis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Lupus Nephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lupus Nephritis and special features on late-stage and discontinued projects. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Companies Mentioned: - Bristol-Myers Squibb Company - Baxter International Inc. - Johnson & Johnson - Biogen Idec Inc. - GlaxoSmithKline plc - Takeda Pharmaceutical Company Limited - Teva Pharmaceutical Industries Limited - Noxxon Pharma AG - Anthera Pharmaceuticals Inc. - Kadmon Pharmaceuticals, LLC - Azano Pharmaceuticals Inc. For more information visit http://www.researchandmarkets.com/research/fd..._nephritis
Final Glance: Pharmaceuticals companies
AP - Mon Jun 09, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Jun 09, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Merck to pay $3.85B for hepatitis C drug developer
By LINDA A. JOHNSON - AP - Mon Jun 09, 4:37PM CDT
TRENTON, N.J. (AP) — Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.
Midday Glance: Pharmaceuticals companies
AP - Mon Jun 09, 12:20PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Jun 09, 12:20PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
By End of 2018 the Global Protein Therapeutics Market is Estimated to Reach US$ 165 Billion as New Products Enter the Sector
M2 - Mon Jun 09, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3s8lj/global_protein) has announced the addition of the "Global Protein Therapeutics Market Outlook 2018" report to their offering. According to this new research report, Global Protein Therapeutics Market Outlook 2018, a large number of market players has been developing monoclonal antibodies (mAbs). This research has found that mAbs contribute the largest shares in the number of protein therapeutic products under pipeline. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments. The report takes into account all the key aspects of the worldwide protein therapeutics market and projects the market during the period 2012-2018. It prudently analyzes all the industry segments in an effective manner by focusing on major players and products, recent developments, application support in terms of indications, geographical performances and last but not the least, current and future market sizes. Moreover, the report provides a summary of the recent trends that may have an impact on the future industry performance. Companies Mentioned: - Abbott Laboratories - Amgen Inc. - Biogen Idec Inc. - Eli Lilly & Company - Johnson & Johnson - Merck Serono S.A. - Novo Nordisk - Pfizer - Roche Group - Sanofi-Aventis For more information visit http://www.researchandmarkets.com/research/c3...al_protein About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Early Glance: Pharmaceuticals companies
AP - Mon Jun 09, 9:30AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Mon Jun 09, 9:30AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Critical Alerts For Groupon, Baidu.com, Johnson and Johnson, First Solar, and Chipotle Mexican Grill Technology Released By InvestorsObserver
PR Newswire - Mon Jun 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GRPN, BIDU, JNJ, FSLR, and CMG.
Achillion Pharma Might be Next Hep C Takeout Target
at The Street - Mon Jun 09, 8:22AM CDT
Johnson & Johnson and Abbvie were both reportedly interesting in buying Idenix but lost out to Merck, reports CNBC. Achillion shares are up almost 30% to $TK Monday as investors bet the losers in the Idenix sweepstakes may move on to the next target.
2014 MedTech Innovator Award Semi-Finalists Announced
Business Wire - Mon Jun 09, 8:01AM CDT
RCT Ventures announced the selection of the Top 10 semi-finalists in the 2014 MedTech Innovator competition, a medical device-focused venture competition that allows the audience to choose the winner. The Top 10 will now move on to compete live on-stage on June 12th for $175,000 in total prizes provided by RCT Ventures, and Johnson & Johnson Development Corporation (JJDC) and Janssen Labs during the 22nd Annual Medical Device Conference, hosted by law firm Wilson Sonsini Goodrich & Rosati (WSGR).
The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
M2 - Mon Jun 09, 4:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kc5qx4/the_world_market) has announced the addition of the "The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)" report to their offering. The Worldwide Market for Infusion Pumps This report, Infusion Pump Markets, is Kalorama Information's most current and complete research into infusion pump devices used for patient treatment and nutrition. With an aging population and increased need for healthcare services, this device is a high-interest area for several manufacturers. Kalorama's report details the important types of infusion pumps, projects revenues and discusses the key companies who manufacture and market them. For the purpose of this study, we have classified two general types of medical infusion pumps: traditional and specialty pumps: Issues and trends explored in this study include: - World demographics - Increasing life expectancy worldwide - Growing incidence of disease - Steady surgical procedure volumes - Infusion pump recalls - Reducing medication errors with new infusion pumps - Smart pump technology - Home infusion trends - Connectivity solutions and wireless networks - EMRs and infusion pump solutions - Infusion pump rentals and leasing - Infusion pumps and 'High-Alert' medications - Reducing hospital inpatient length of stay and increases in home health care - Medical device growth in emerging markets Several leading competitors and niche product developers are listed in the Manufacturer Profiles. The profiled companies include: - Animas/Johnson & Johnson - Baxter - B. Braun - CareFusion - Covidien - Fresenius Kabi - Hospira - I-Flow - Insulet - IRadimed - Medtronic - Moog - Roche - Smiths Group - Tandem Key Topics Covered: 1: EXECUTIVE SUMMARY 2: INDUSTRY OVERVIEW 3: MARKET TRENDS AND OPPORTUNITIES 4: TRADITIONAL INFUSION PUMPS 5: SPECIALTY INFUSION PUMPS 6: TOTAL MARKET ANALYSIS 7: MANUFACTURER MARKET SUMMARY AND PROFILES For more information visit http://www.researchandmarkets.com/research/kc...rld_market
Various Walmart Suppliers Supporting Children's Miracle Network Hospitals This Month
PRWeb - Mon Jun 09, 4:15AM CDT
As the six-week Walmart and Sam's Club register campaign wraps up this month, several Walmart initiatives and suppliers are continuing the effort to raise funds and awareness for Children's Miracle Network Hospitals, a charity supporting 170 children's hospitals across North America. Below are some of the upcoming activities: Through a relationship with Walmart supplier Proctor & Gamble, The ABC Family television series, Bet On Your Baby, will feature CMN Hospitals Miracle Child Joshua on Saturday, June 14 at 8:00 p.m. EST. Mom bloggers and consumers will be live tweeting throughout the episode from 8-9 p.m. EST. For each use of the #LuvsBOYB hashtag, one Luvs diaper will be donated to CMN Hospitals (up to 10,000 diapers). On June 17 at noon EST, Johnson & Johnson will host a Twitter party to build buzz around the Johnson Baby promotion where $1 from select purchases will benefit CMN Hospitals in June. Consumers can join the conversation by following the hashtaag #JohnsonBabyCARES. Now through August, Walmart supplier Johnson & Johnson will also donate $1 for photos shared on the Donate A Photo app. Users must select Children's Miracle Network Hospitals as the benefiting charity. Watch for specially marked Johnson & Johnson products for more details. CMN Hospitals signage in the Walmart Baby department will start appearing in stores across the nation this month featuring Miracle Child Ella and inviting customers to Put Your Money Where the Miracles Are. During June, $1 per purchase of any Johnson's Baby, Aveeno Baby and Desitin items, along with Infant Tylenol and Infant Motrin, up to $200,000, will go to CMN Hospitals. A portion of proceeds, up to $200,000, from all sales of Gerber products from May 14 - June 28 will benefit Children's Miracle Network Hospitals. Pampers and Walmart are also partnering to donate $200,000 to the charity. White Cloud, a paper products company, recently announced the winners of its tissue box design contest with Children's Miracle Network Hospitals. Four patients will have their artwork printed on special edition tissue boxes available exclusively at Walmart through June, and also earned a $15,000 donation and a yearlong supply of paper products for their hospitals. White Cloud will also donate an additional $95,000 to the charity and member hospitals. To find your Children's Miracle Network Hospital or for more information and to help kids in your community, visit http://www.CMNHospitals.org.
The Repercussions of Medicare's New Hepatitis C Push
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Sun Jun 08, 12:31PM CDT
This week, the Centers for Medicare & Medicaid Services, or CMS, announced a big shift in health policy. CMS intends to cover screening for hepatitis C for members who fall into either of two buckets: those who are considered to be at high risk...
3 Spectacular Ways Samsung Could Disrupt the Health Care Industry
Leo Sun, The Motley Fool - Motley Fool - Sat Jun 07, 10:05AM CDT
When most investors think of Samsung , they inevitably think of smartphones, tablets, and TVs. Yet over the past several years, Samsung has also beefed up its presence in the health care industry through investments in medical devices,...
As Dividend Stocks Go, Philip Morris Is Expensive: Here Is a Cheaper Pick
Rupert Hargreaves, The Motley Fool - Motley Fool - Sat Jun 07, 9:00AM CDT
Every portfolio should have a dividend stock at its core to provide a degree of diversification and stability. The best dividend stocks are usually found within the consumer goods sector as the sector's defensive nature means that cash flows are...
